Tissue velocity imaging of the left atrium predicts response to flecainide in patients with acute atrial fibrillation

Electro-echocardiographic atrial TVI measurement is a promising noninvasive tool for predicting outcome of pharmacological cardioversion. A short AFCL-TVI and a low AFV-TVI are related to failure of cardioversion of AF using flecainide.